EAS Blog
EAS Independent Consultants and staff provide in-depth regulatory expertise and authoritative reporting on a variety of compliance requirements for industries that EAS serves. Our experts break down complicated topics into easily understandable summaries and analysis. Subscribe to our newsletter and receive these monthly updates directly in your in-box.
Food Standards Australia New Zealand
Food Standards Australia New Zealand (FSANZ) has compiled all 80 Standards and 29 Schedules of the Code into a single, easy-to-search and navigate guidance document. While an obvious resource for Australian and New Zealand based food businesses, it is also a great resource for businesses exporting...
Cosmetic Registration and Listing Requirement Reminder
Now that we have entered the first year post cosmetic registration and listing requirements, it’s a good time to review your records and make sure you are prepared for your update / renewal process. For facility registrations, an update should be submitted within 60 days of any changes to the...
Audits: Internal, Regulatory, and Mock…. Oh, My!
Audits come in a variety of types, but the three main audit types that will be covered here are Regulatory Audits, Internal Audits, and Mock Audits. The ways a company handles, conducts and views these three categories of inspections will set them up for success. Read more of Jeb Hunter's featured...
Drug and Device Corner January 2025
Effective January 20, 2025, The President issued a Regulatory Freeze Executive Order, which will have a direct impact on regulated industries. The regulatory freeze order, consistent with the actions of previous incoming administrations, effectively halts any rulemaking or similar regulatory...
Regulatory Freeze Executive Order
Effective January 20, 2025, President Trump issued a Regulatory Freeze Executive Order, which will have a direct impact on regulated industries. Regulatory Freeze The regulatory freeze order, consistent with the actions of previous incoming administrations, effectively halts any rulemaking or...
Cat and Dog Food Manufacturers Required to Consider H5N1 in Food Safety Plans
January 17, 2025Read on FDA WebsiteThe U.S. Food and Drug Administration has determined that it is necessary for manufacturers of cat and dog foods who are covered by the FDA Food Safety Modernization Act Preventive Controls for Animal Food (PCAF) rule and using uncooked or unpasteurized materials...
FDA Issues Proposed Rule on Front-of-Package Nutrition Labeling
On January 14, 2025, the U.S. Food and Drug Administration (FDA) announced a proposed rule to require a front-of-package (FOP) nutrition label on most packaged foods to provide accessible, at-a-glance information to help consumers quickly and easily identify how foods can be part of a healthy...
A Year in Review: FDA’s Progress on Tobacco Product Regulation in 2024
With a new year upon us, FDA’s Center for Tobacco Products (CTP) continues to work diligently to protect the public health of the U.S. population from tobacco-related disease and death. At the same time, we also celebrate significant public health wins that have occurred over the past year,...
FDA Proposes Significant Step Toward Reducing Nicotine to Minimally or Nonaddictive Level in Cigarettes and Certain Other Combusted Tobacco Products
Today, the U.S. Food and Drug Administration issued a proposed rule that, if finalized, would make cigarettes and certain other combusted tobacco products minimally or nonaddictive by limiting the level of nicotine in those products. If finalized, the United States would be the first country...
Guidance for Industry: Questions and Answers Regarding Food Allergen Labeling (Edition 5)
January 2025 Docket Number: FDA-2022-D-0099 Issued by: Human Foods ProgramFinal Guidance for Industry: Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling Requirements of the Federal Food, Drug, and Cosmetic Act (Edition 5). This final guidance will replace both...
Considerations for Complying with 21 CFR 211.110
January 2025 Docket Number: FDA-2024-D-5374 Issued by: Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Center for Veterinary MedicineThis guidance, when finalized, will describe considerations for complying with the requirements in 21 CFR 211.110 to ensure...
Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations
Docket Number: FDA-2024-D-4488Issued by: Center for Devices and Radiological HealthCenter for Biologics Evaluation and ResearchCenter for Drug Evaluation and ResearchThis draft guidance document provides recommendations regarding the contents of marketing submissions for devices that include...
Pet Supplement Industry on the Rise
By Tim Lombardo, EAS Senior Director for Food Consulting ServicesRecent survey reports indicate that supplements for pets have reached US sales of nearly $3 billion, with dog and cat supplements comprising of approximately 75% and 20% of the total, respectively. The growing pet supplement market...
Guidance for Industry: Action Levels for Lead in Processed Food Intended for Babies and Young Children
January 2025 Docket Number:FDA-2022-D-0278 Issued by: Human Foods ProgramFDA is committed to reducing lead in food. FDA’s Closer to Zero initiative is a science-based, iterative approach to decreasing toxic elements, including lead, in foods over time, including by setting action levels. The...
FDA Issues Final Guidance on Analytical Testing for Industry Use in Tobacco Product Applications
Agency remains committed to providing resources to support application submissionsJanuary 6, 2025Today, FDA issued “Validation and Verification of Analytical Testing Methods Used for Tobacco Products,” a final guidance providing tobacco manufacturers with information and recommendations to aid...
Claims Substantiation Seminar
This two-hour training will be a scientific dive into the regulatory requirement of claims substantiation. Several topics including the following will be discussed along with real case examples: which types of evidence are available and where to find them; what are high quality and low quality evidence; when is the evidence irrelevant to the claim being made; and how to write claims that can be substantiated.
Drug and Device Corner December 2024
The FDA issued a final rule establishing requirements for a nonprescription drug product with an Additional Condition for Nonprescription Use (ACNU). This new marketing pathway will allow the sale of a nonprescription drug product directly to a consumer once the user completes an ACNU...
FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products
For Immediate Release: December 26, 2024Today, the U.S. Food and Drug Administration (FDA) announced a proposed rule to establish and require standardized testing methods to detect and identify asbestos in talc-containing cosmetic products. This proposed rule, if finalized, will help protect...
FDA issues final rule to broaden types of nonprescription drugs available to consumers
Today, the U.S. Food and Drug Administration issued a final rule establishing requirements for a nonprescription drug product with an additional condition for nonprescription use (ACNU). A nonprescription drug product with an ACNU is a drug product that could be marketed without a prescription if...
FDA Updates “Healthy” Claim, Providing a Refreshed Tool for Consumers
December 19, 2024Today, the U.S. Food and Drug Administration is announcing a final rule to update the definition of the nutrient content claim “healthy.” There is an ever-growing crisis of preventable, diet-related chronic diseases in the U.S. that requires immediate action. The updated “healthy”...